<DOC>
	<DOCNO>NCT01169129</DOCNO>
	<brief_summary>Patients good general condition resectable brain metastasis , look good intense treatment metastasis . This local treatment accomplish surgery radiosurgery . However , randomized study compare two type treatment . The purpose study make .</brief_summary>
	<brief_title>Surgery Whole Brain Radiotherapy ( RT ) Versus Whole Brain Radiotherapy ( RT ) Radiosurgery 1-3 Resectable Brain Metastases</brief_title>
	<detailed_description>Patients good general condition resectable 1-3 brain metastasis randomize surgery whole brain radiotherapy whole brain radiotherapy radiosurgery . Initially evaluate feasibility carry study 15 patient arm , , follow primary end-point compare toxicity exclusively radiotherapy arm complication surgical arm . As secondary end-point , evaluate local recurrence-free survival , overall survival , distance cerebral relapse-free survival ( metachronous brain metastasis ) , free neurological progression survival , free neurological death survival , free dependent life ( another person ) survival , steroid-free survival quality life .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<criteria>Histopathology primary tumor : primary small cell cancer , germ cell tumor , leukemia , lymphoma , primary central nervous system . Primarysite : control , mean operate / irradiate ; without detectable local tumor activity Lack extracranial metastasis Absence prior brain irradiation Number brain metastasis : 13 Location brain metastasis : brain region eligible surgery ( noneloquent area ) RC ( metastases large diameter ≤ 3 cm , volume &lt; 15 mL , &gt; 5 mm optic chiasm , optic nerve , thalamus , hypothalamus , basal ganglia base , optic tract , optic radiation , midbrain , pons , medulla , corpus callosum , internal capsule , hippocampus amygdala , &lt; 10 ml brain tissue receive ≥ 12 Gy ) . Metastasisthat cause significant mass effect hydrocephalus herniation require urgent surgical intervention Second uncontrolled primary tumor site : none , except nonmelanoma skin cancer Absence comorbid condition prevents surgery resection brain metastasis Absence connective tissue disease lupus erythematosus scleroderma Patients chemotherapy need chemotherapy treatment suspend . Patients must consent follow clinical staff Barretos Cancer Hospital ( HCB ) . KPS : ≥ 70 % Neutrophils ≥ 1800 cell / mL 14 day prior study entry Platelets ≥ 100,000 cell / mL 14 day prior study entry Hemoglobin ≥ 10 g / dL 14 day prior enter study ( transfusion allow achieve require concentration ) Creatinine ≤ 1.7 mg / dL 14 day prior study entry BUN ≤ 30 mg / dL 14 day prior entry study Bilirubin ≤ 2 mg / dL 14 day prior study entry TGO/TGP Up three time normal examination 14 day prior study entry Prothrombin timeINR &lt; 1.4 examination 14 day prior study entry Systolic pressure ≤ 160 mm Hg diastolic pressure ≤ 90 mm Hg examination 14 day prior study entry Electrocardiogramwithout acute myocardial infarction examination 14 day prior study entry No active bleed pathological condition entail high risk bleed Negative pregnancy test least 14 day prior study entry Informed Consent : The patient inform investigational nature treatment enter study agree participate study sign consent form informs side effect possible benefit potential modality treatment . Metastasis posterior fossa , patient operate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>brain metastasis</keyword>
	<keyword>radiosurgery</keyword>
	<keyword>neurosurgery</keyword>
	<keyword>surgery</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>resectable brain metastasis</keyword>
</DOC>